This presentation summarizes the Global Alliance to Eliminate Lymphatic Filariasis. It includes slides on the endemicity and clinical manifestations of LF, the economic burden it causes, its transmission and elimination strategy through mass drug administration and morbidity management, the partnership of the Global Alliance, progress made in treatment numbers, and opportunities for integration with other health programs. The presentation provides an overview of LF and the work of the Global Alliance to eliminate this disease.
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
L Fslidetemplate
1. Sample Slide Presentation
The Global Alliance to Eliminate Lymphatic Filariasis
This presentation may be useful as an introduction to the Global Programme to Eliminate
Lymphatic Filariasis. Presenters may want to substitute or add slides to show the impact
of LF on a specific country or region.
Slide 1: Title slide with the logo of the Global Alliance to Eliminate Lymphatic
Filariasis
Slide 2: An overview slide of LF: endemicity, at-risk population, infected
population and map highlighting countries with LF
Slide 3: The disabling clinical manifestations of LF with images of elephantiasis
and lymphoedema of the legs and elephantiasis of the scrotum
Slide 4: A summary of the economic burden of LF on individuals and communities
Slide 5: While the clinical signs and symptoms of LF usually appear during
puberty and adulthood, LF is a childhood infection
Slide 6: The elimination strategy is two-pillared. This slide is an overview of both
strategies.
Slide 7: This slide explains the strategy to stop transmission of LF infection
through annual treatment with medicines or DEC-fortified salt
Slide 8: The second pillar of the elimination program is to alleviate and prevent
disability by taking care of the affected limb(s) or surgery for hydroceles
Slide 9: The Global Alliance consists of the Ministries of Health of LF endemic
countries along with 40 partner organizations
Slide 10: A graph showing the impressive increase in the number of people treated
since the start of the programme
Slide 11: A graph showing a regional breakdown of treatments administered in 2004
Slide 12: Many opportunities for integration with community-based health care
programs exist. This slide list just a few possible platforms – you may
have more to add
Slide 13: This concluding slide summarizes the presentation and leaves the audience
with a call to action.
22-Jun-05